Description
The NIH’s Institutional Development Award (IDeA) for Clinical & Translational Research (CTR) is a limited‑competition grant aimed at building biomedical research capacity in historically under‑funded states. Applicants must be lead or partner institutions located in an IDeA‑eligible state and cannot already hold a CTSA or another active IDeA‑CTR award. Two tracks are offered:
• CTR‑Development (CTR‑D) – focuses on workforce development and infrastructure enhancement at institutions with limited clinical research capacity.
• CTR‑Network (CTR‑N) – supports statewide or multi‑state networks to expand infrastructure, develop the research workforce, and coordinate clinical research activities across IDeA states.
Key points for potential applicants:
• Only one application per organization.
• Lead institutions must already have externally‑funded C&T research.
• Partner institutions must be in the same state or multi‑state region as the lead.
• Applications are submitted via the NIH eRA Commons by May 30, 2029; anticipated award start July 16, 2027.
• Funding is provided as a grant (no cost‑sharing required) with no published ceiling; typical award sizes range from $1‑5 million over up to five years.
• Reporting includes annual RPPRs and final close‑out documentation.
• Primary contacts are the NIGMS IDeA CTR scientific contact (email above) and the NIGMS financial contact ([email protected]).